Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: A randomized, double-blinded, multicenter, controlled trial

Veterinary Therapeutics

Volumn 8, Issue 4, 2007, Pages 272-284

  Black, Linda L ^a   Gaynor, James ^b   Gahring, Dean ^c   Adams, Cheryl ^d   Aron, Dennis ^e   Harman, Susan ^a   Gingerich, Daniel A ^f   Harman, Robert ^a  

^a Vet Stem Inc   (United States)

^b Animal Anesthesia and Pain Management Center   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Arboretum View Animal Hospital   (United States)

^e Veterinary Surgical Specialists   (United States)

^f Turtle Creek Biomedical Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ADIPOSE TISSUE; ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DOG; DOG DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; INTRAARTICULAR DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTICENTER STUDY; PAIN ASSESSMENT; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

ADIPOSE TISSUE; ANIMALS; DOGS; DOUBLE-BLIND METHOD; FEMALE; HIP DYSPLASIA, CANINE; INJECTIONS, INTRA-ARTICULAR; LAMENESS, ANIMAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; UNITED STATES;

EID: 39749132308     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Luyten FP: Mesenchymal stem cells in osteoarthritis. Curr Opin Rheumatol 16(5):599-603, 2004.
2. Parker A, Katz A: Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 6:567-578, 2006.
3. Schaffler A, Buchler C: Concise review: Adipose tissue-derived stem cells - Basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827, 2007.
4. Fraser J, Wulur I, Alfonso Z, et al: Fat tissue: An underappreciated source of stem cells for biotechnology. Trends Biotech 4:150-154, 2006.
5. Strem BM, Hicok KC, Zhu M, et al: Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54(3):132-410, 2005.
6. Nakagami H, Morishita R, Maeda K, et al: Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 13(2): 77-81, 2006.
7. Tholpady SS, Llull R, Ogle RC, et al: Adipose tissue: stem cells and beyond. Clin Plast Surg 33(1):55-62, 2006.
8. Gimble J, Katz A, Bunnell A: Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249-1260, 2007.
9. Zuk PA, Zhu M, Mizuno H, et al: Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7(2):211-228, 2001.
10. Varma M, Breuls R, Schouten T, et al: Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev 16:91-104, 2007.
11. Yoshimura K, Shigeura T, Matsumoto D, et al: Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Phys 208:64-76, 2006.
12. Boquest A, Shahdadfar A, Fronsdal K, et al: Isolation and transcription profiling of purified uncultured human stromal stem cells: Alteration of gene expression after in vitro cell culture. Mol Biol Cell 16:1131-1141, 2005.
13. Harman R, Cowles B, Orava C, et al: A retrospective review of 62 cases of suspensory ligament injury in sport horses treated with adipose-derived stem and regenerative cell therapy. Proc Vet Orthop Soc, 2006.
14. Vet-Stem, Inc. Data on file, 2005.
15. Dahlgren LA. Use of adipose derived stem cells in tendon and ligament injuries. Am Coll Vet Surg Symp Equine Small Anim Proc: 150-151, 2006.
16. Nixon A, Dahlgren L, Haupt J, et al: Effect of adipose-derived nucleated cell fractions on tendon repair in a collagenase-induced tendinitis model. Am J Vet Res, accepted for publication, 2007.
17. Murphy JM, Fink DJ, Hunziker EB, et al: Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48(12):3464-3474, 2003.
18. Guilak F, Awad HA, Fermor B, et al: Adipose-derived adult stem cells for cartilage tissue engineering. Biotechnology 41(3-4):389-99, 2004.
19. Nathan S, Das De S, Thambyah A, et al: Cell-based therapy in the repair of osteochondral defects: A novel use for adipose tissue. Tissue Eng 9(4):733-744, 2003.
20. Hedhammar A, Olsson SE, Andersson SA, et al: Canine hip dysplasia: Study of heritability in 401 litters of German Shepherd dogs. JAVMA 174:1012-1016, 1979.
21. Johnson JA, Austin C, Breur GJ: Incidence of canine appendicular musculoskeletal disorders in 16 veterinary teaching hospitals from 1980 to 1989. Vet Comp Orthop Traumatol 7:56-69, 1994.
22. Moore GE, Burkman KD, Carter MN, et al: Causes of death or reasons for euthanasia in military working dogs: 927 cases (1993-1996). JAVMA 219:209-214, 2001.
23. Mortellaro CM: Pathophysiology of osteoarthritis. Vet Res Comm 27(Supp 1):75-78, 2003.
24. Lascelles BD, Main DC: Surgical trauma and chronically painful conditions - Within our comfort level but beyond theirs? JAVMA 221:215-222, 2002.
25. Budsberg SC, Johnston SA, Schwarz PD, et al: Efficacy of etodolac for treatment of osteoarthritis of the hip joints in dogs. JAVMA 214:206-210, 1999.
26. Holtsinger RH, Parker RB, Beale BS, et al: The therapeutic efficacy of carprofen (Rimadyl-V) in 209 clinical cases of canine degenerative joint disease. Vet Comp Orthop Traumatol 5:144-144, 1992.
27. Vasseur P, Johnson A, Budsberg S, et al: Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. JAVMA 206(6):807-811, 1995.
28. Johnson SA, Budsberg SC: Nonsteroidal anti-inflammatory drugs and corricosteroids for the management of canine osteoarthritis. Vet Clin North Am Small Anim Pract 27:841-862, 1997.
29. Caplan A, Dennis J: Mesenchymal stem cells as trophic mediators. J Cell Biochemistry 98:1076-1084, 2006.
30. Spees JL, Olson SD, Whitney NJ, et al: Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A 103(5):1283-1288, 2006.
31. Gingerich D, Strobel J: Use of client-specific outcome measures to assess treatment effects in geriatric, arthritic dogs: Controlled clinical evaluation of a nutraceutical. Vet Ther 4(1):56-66, 2003.
32. McAlindon TM, LaValley MP, Gulin JP, et al: Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and meta-analysis. JAMA 283(11):1469-1475, 2000.
33. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988.
34. Jevens DJ, DeCamp CE, Hauptman J, et al: Use of force plate analysis of gait to compare two surgical techniques for treatment of cranial cruciate ligament rupture in dogs. Am J Vet Res 57:389-393, 1996.
35. Rumph PF, Kincaid SA, Visco DM, et al: Redistribution of vertical ground reaction force in dogs with experimentally induced chronic hind limb lameness. Vet Surg 24:384-389, 1995.
36. Rumph PF, Kincaid SA, Baird DK, et al: Vertical ground reaction force distribution during experimentally induced acute synovitis in dogs. Am J Vet Res 54:365-369, 1993.
37. Cross AR, Budsberg SC, Keefe TJ: Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs. Am J Vet Res 58:626-631, 1997.
38. Budsberg SC, Chambers JN, Van Lue SL, et al: Prospective evaluation of ground reaction forces in dogs undergoing unilateral total hip replacement. Am J Vet Res 57:1781-1785, 1996.
39. Quinn M, Keuler N, Lu Y, et al: Evaluation of agreement between numerical rating scales, visual analogue scoring scales, and force plate gait analysis in dogs. Vet Surg 36:360-367, 2007.
40. Nasef A, Mathieu N, Chapel A, et al: Immunosuppressive effects of mesenchymal stem cells: Involvement of HLA-G. Transplantation 84:231-237, 2007.
41. Le Blanc K: Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy 8:559-561, 2006.
42. Fang B, Song Y, Lin Q, et al: Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr Transplant 11 (7):814-817, 2007.
43. Ortiz LA, DuTreil M, Fattman C, et al: Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104:11002-11007, 2007.
44. Koopman WJ, Moreland LW (eds). Arthritis and Allied Conditions: A Textbook of Rheumatology, ed 15. Philadelphia, Lippincott Williams & Wilkins, 2005.
45. Frisbie DD, Ghivizzani SC, Robbins PD, et al: Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 9:12-20, 2002.
46. Malyak M, Swaney RE, Arend WP: Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils. Arthritis Rheum 36:781-789, 1993.
47. Martel-Pelletier J, Pelletier JP: Importance of interleukin-1 receptors in osteoarthritis. Rev Rhum Ed Fr 61:109S-113S, 1994.
48. Chopp M, Zhang XH, Li Y, et al: Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 11(13):3001-3005, 2000.